The High-Quality Complete Genome Sequence of the Opportunistic Fungal Pathogen Candida vulturna CBS 14366T
Candida vulturna is a new member of the Candida haemulonii species complex that recently received much attention as it includes the emerging multidrug-resistant pathogen Candida auris. Here, we describe the high-quality genome sequence of C. vulturna type strain CBS 14366T to cover all genomes of pathogenic C. haemulonii species complex members.
KeywordsCandida vulturna Candida haemulonii species complex Nanopore sequencing Emerging pathogen De novo genome assembly
Candida vulturna was recently described as a member of the Candida haemulonii species complex that currently comprises nine species of which four are known as human pathogens: C. haemulonii (including the variety vulnera), Candida pseudohaemulonii, Candida duobushaemulonii and C. auris [1, 2, 3]. The type strain of C. vulturna was first described in 2016, originated from a flower, but since then several cases of C. vulturna invasive candidiasis were reported in Malaysian patients (Ratna Mohd Tap, personal communication; ).
There are several genomes published of pathogenic C. haemulonii species complex members, mostly being C. auris , and single or few genomes of C. haemulonii , C. duobushaemulonii  and C. pseudohaemulonii [8, 11]. Unfortunately, C. vulturna has not been considered in previous genome sequencing projects. Therefore, we sequenced a high-quality genome of this emerging fungal pathogen.
Candida vulturna CBS 14366T was cultured in 10 ml yeast peptone glucose broth for 3 days at 25 °C on a rotary shaker (125 rpm). Strain identity was confirmed by standard ITS sequencing (GenBank MN330068; ); however, MALDI-TOF analysis (Brüker-Daltonics, Bremen, Germany) yielded repetitively a good, yet incorrect, hit with its sibling C. pseudohaemulonii.
An established cetyltrimethylammonium bromide (CTAB) DNA extraction protocol was optimized to yield high quantity and quality genomic DNA, as in detail described hereafter . Biomass was collected by centrifugation at 4,000 rpm for 10 min (Centrifuge 5810R; Eppendorf, Hamburg, Germany), supernatant was decanted, and 1.5 ml CTAB-buffer (see ) containing 1 mg proteinase K (V3021, Promega, Leiden, The Netherlands) was added followed by 2 h incubation at 60 °C with periodically vortexing. The sample was cooled to room temperature, and 2 ml chloroform/isoamyl alcohol (24:1) was added and mixed by 5–10 min flipping. After centrifugation at 4,000 rpm for 10 min, the supernatant (~ 1200 µl) was collected in a 2.0-ml DNA low-binding tube (0030108078; Eppendorf). DNA was precipitated by adding 660 µl ice-cold 2-propanol (I9516; Sigma-Aldrich, Saint Louis, MO, USA) and mixed by flipping. DNA yield increased by overnight incubation at -20 °C. After centrifugation at 14,000 rpm (Centrifuge 5430; Eppendorf) for 10 min, supernatant was removed and the pellet was washed with 1 ml 70% ice-cold ethanol. The dried pellet was resuspended in 150 µl IDTE-buffer (10 mM Tris, 0.1 mM EDTA, pH 8; IDT, San Diego, CA, USA); more IDTE was added until the pellet dissolved completely. RNA was removed by adding 1 µl RNAse Cocktail Enzyme mix (AM2286; ThermoFisher, Waltham, MA, USA) per 100 µl sample and incubated for 1 h at 37 °C. DNA samples were again washed with chloroform/isoamyl alcohol and precipitated with 2-propanol as described above. DNA quality and quantity were measured in triplicate using Qubit and Nanodrop (both ThermoFisher); purity and integrity was checked on 0.8% agarose gel. DNA was stored at -20 °C until further use.
Library preparation was done by the ligation sequencing kit (SQK-LSK108; ONT, Oxford, UK) followed by the nanopore sequencing run on a MinION flow cell (FLO-MIN106; ONT) according to the manufacturer’s instructions.
Basecalling of raw data was performed using Guppy (v3.2.2 + 9fe0a78; parameters: –flow cell FLO-MIN106 –kit SQK-LSK108) . A draft assembly was prepared using Canu (v1.8; parameters: genomeSize = 13 m -nanopore-raw) . The raw reads produced by Guppy were re-mapped into the draft genome using minimap2 (v 2.17-r954-dirty; parameters: -L -ax map-ont) . The draft assembly was polished twice, first with racon (v1.4.6; parameters: -m 8 -x -6 -g -8 -t 6) and, after manual inspection and curation, with medaka (v0.8.1-p; parameters: -m r941_min_high) [15, 16].
Assembly of the Candida vulturna CBS 14366T reads produced 8 scaffolds between 4.2Mbp and 300Kbp (N50 = 1,937,935 bp), and a shorter scaffold of 43Kbp whose best blast hit within the NCBI database is annotated as mitochondrial DNA (Candida auris JCM 15448 = CBS 10913T; accession AP018713) for a total of 12.9Mbp. The 9 scaffolds likely correspond to 8 chromosomes plus the mitochondrial genome; similar numbers have been reported for other pathogenic members of the C. haemulonii species complex [8, 9, 10, 17, 18]. Draft genome was analyzed with funannotate (v1.6.0-297abc4; https://github.com/nextgenusfs/funannotate). Genes (n = 5,560) were predicted ab initio and functionally annotated with Pfam (v32), InterProScan (v75), BuscoDB (Saccharomycetales_odb9) and eggnog (v5.0).
This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the BioProject accession number PRJNA560499. The version described in this paper is the first version. The Sequence Read Archive (SRA) accession number is SRR10142922, associated with the BioSample number SAMN12587626.
Jorge C. Navarro-Muñoz was financially supported by the Stichting Odo van Vloten Foundation, The Netherlands.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M, Cuenca-Estrella M, Gómez-López A, Boekhout T. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol. 2012;50:3641–51. https://doi.org/10.1128/JCM.02248-12.CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41–4. https://doi.org/10.1111/j.1348-0421.2008.00083.x.CrossRefPubMedGoogle Scholar
- 8.Muñoz JF, Gade L, Chow NA, Loparev VN, Juieng P, Berkow EL, Farrer RA, Litvintseva AP, Cuomo CA. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun. 2018;9:5346. https://doi.org/10.1038/s41467-018-07779-6.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Chow NA, Gade L, Batra D, Rowe LA, Juieng P, Ben-Ami R, Loparev VN, Litvintseva AP. Genome sequence of a multidrug-resistant Candida haemulonii isolate from a patient with chronic leg ulcers in Israel. Genome Announc. 2018;6:e00176-18. https://doi.org/10.1128/genomeA.00176-18.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Gerrits van den Ende AHG, de Hoog GS. Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud Mycol. 1999;43:151–62.Google Scholar
- 18.Oh BJ, Shin JH, Kim MN, Sung H, Lee K, Joo MY, Shin MG, Suh SP, Ryang DW. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol. 2011;49:98–102. https://doi.org/10.3109/13693786.2010.493563.CrossRefPubMedGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.